Membralox® UF Membranes and Schumasiv™ MF Filter Elements
Handle Difficult Oil/Water and Sludge/Water Separations

PORT WASHINGTON, NY, March 31, 2015 – One of China’s largest steel manufacturers is relying on Pall technology for critical process separations. Pall Membralox® ceramic UF membranes are being employed for oil/water separations and Pall Schumasiv™ ceramic MF membrane filter elements are being used for bioreactor sludge/water separations. The plant has a capacity of several million tons/year.
 
In steel production, “rolling” is a metal-forming process in which metal stock is passed through one or more pairs of rollers to reduce thickness and provide uniformity. An oil/water emulsion is used as a lubricant and for heat control in this process. After this process, Membralox ceramic membranes help concentrate the emulsion, enabling the oil to be reclaimed and the water to be sent to the membrane bioreactor to reduce the amount of organic compounds in the water. 
 
A concentrated sludge/water mixture is a by-product of the ensuing bioreaction. Schumasiv ceramic membranes are used to separate the sludge and water, enabling the sludge to be safely disposed of and allowing the water to be reclaimed for re-use. 

“Fluid cleanliness is critical to the operation and reliability of the systems used in steel production,” said Mitch Summerfield, President, Pall Process Systems. “Pall technology is enabling this plant to deliver the consistent, high-quality product which its customers demand.”

Pall’s Membralox membranes and Schumasiv filter elements are designed for a wide range of industrial processes. The ceramic membranes are less prone to fouling and offer greater reliability in handling process upsets than the traditional settling tank and polishing filtration which the MF system replaced.
 
In addition, they provide high-quality filtrate, such that the plant no longer needs to install a traditional large post-aerobic clarifier. The reduced footprint resulted in significant savings for the plant. The Pall system also eliminated the need for additional downstream polishing equipment, further reducing capital and operation costs. Finally, Pall’s systems feature innovative modular designs, which will make future plant expansion simpler and less expensive.

About Pall Corporation
Pall Corporation (NYSE:PLL) is a filtration, separation and purification leader providing solutions to meet the critical fluid management needs of customers across the broad spectrum of life sciences and industry. Pall works with customers to advance health, safety and environmentally responsible technologies. The company’s engineered products enable process and product innovation and minimize emissions and waste. Pall Corporation is an S&P 500 company serving customers worldwide. Follow us on Twitter @PallCorporation or visit www.pall.com.

Media Contact:
Robert Emproto
Pall Industrial Marketing Communications
Telephone: 516-801-9341
Email: Robert_Emproto@pall.com

More Pall Corporation Press Releases
July 2019
July 16, 2019: Servier chooses Pall as exclusive technology and services provider for planned Bio-S biomanufacturing facility in France
April 2019
April 29, 2019: Freeline's (AAV) manufacturing platform and Pall’s iCELLis bioreactor system combine to achieve commercial-scale and high quality production of AAV gene therapy vectors
March 2019
March 19, 2019: New lab will serve as a dedicated platform where the industry can access shared resources including equipment, expertise and project work to find innovative solutions to manufacturing needs for biologic medicines, such as cell-based immunotherapies
March 13, 2019: Pall Biotech to distribute ARTeSYN’s standard hardware and liner components for fluid flow control. Customers to benefit from the flexibility, agility and reliability required for their bioprocessing journey, with accelerated implementation of robust and standardized single-use fluid management and control
March 11, 2019: Pall Biotech to integrate and distribute Broadley-James’ advanced single-use probe and flow cell pH sensors; sensor will be integrated into Pall Biotech’s single-use technologies
March 1, 2019 - Pall Corporation Obtains FAA PMA Approval and extends its Advanced Cabin Air Filters (A-CAF) product line to Boeing.
December 2018
December 18, 2018: New centre to give Pall customers options ranging from batch to single use and continuous bioprocessing solutions, and to provide technology solutions that meet current needs, while offering some of the most progressive technological solutions for the future
November 2018
November 26, 2018: Cobra and Pall to make commercialisation of gene therapies safer, faster, and cheaper than ever before, help increase patient access to gene therapy and further establish best practices in manufacturing
October 2018
October 2, 2018: New centre will work to enhance drug production and empower the future workforce, reinforcing Pall's commitment to continuously improve bioprocesses through strategic partnerships
September 2018
September 24, 2018: New collaboration to see G-CON PODs customized with Pall technologies, addressing customer demand for higher efficiencies, while enjoying more flexibility through scale-out and localization of manufacturing